ABCG2 and cancer: Several putative stem cell markers, such as CD44, CD24, CD166, EpCAM, ABCG2, CD133, and podoplanin, are commonly studied in identifying and isolating the CSCs from the solid tumors; however, subsequent studies demonstrated that the choice of CSC markers differs among cancer originations [10–15].